Sort
261,768 grants matching “gene therapy”
Developmental and Hyperactive Ras Tumor (DHART) SPORE
$2,139,494David W. Clapp · Indiana University Indianapolis · U54 · FY2022 · CA
Canine Hereditary Cancer Consortium: From Bark to Bedside
$2,139,485Jeffrey M. Trent · Translational Genomics Research Inst · UC2 · FY2010 · CA
National Biological Sample and Data Repository for PAH
$2,139,162William C Nichols · Cincinnati Childrens Hosp Med Ctr · R24 · FY2012 · HL
Noroviruses and Epidemic Gastroenteritis
$2,139,101Kim Y. Green · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
SPORE for Translational Approaches to Brain Cancer
$2,139,000Maciej S Lesniak · Northwestern University At Chicago · P50 · FY2021 · CA
SPORE for Translational Approaches to Brain Cancer
$2,139,000Maciej S Lesniak · Northwestern University At Chicago · P50 · FY2019 · CA
DF/HCC Kidney Cancer SPORE
$2,139,000David McDermott · Beth Israel Deaconess Medical Center · P50 · FY2019 · CA
Neuroendocrine Tumor Specialized Programs of Research Excellence (SPORE) in Human Cancer
$2,139,000Dawn E Quelle · University Of Iowa · P50 · FY2019 · CA
SPORE in Myeloid Malignancies
$2,138,999Benjamin Levine Ebert · Dana-Farber Cancer Inst · P50 · FY2019 · CA
SPORE in Myeloid Malignancies
$2,138,999Benjamin Levine Ebert · Dana-Farber Cancer Inst · P50 · FY2021 · CA
SPORE for Translational Approaches to Brain Cancer
$2,138,999Maciej S Lesniak · Northwestern University At Chicago · P50 · FY2022 · CA
MSK SPORE in Lymphoma
$2,138,999Andrew D. Zelenetz · Sloan-Kettering Inst Can Research · P50 · FY2020 · CA
Pathobiology and treatment of patients with inborn errors of immunity
$2,138,853Sung-Yun Pai · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
SPORE in Bladder Cancer
$2,138,849Dean F. Bajorin · Sloan-Kettering Inst Can Research · P50 · FY2019 · CA
SPORE in Bladder Cancer
$2,138,849Dean F. Bajorin · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA
Imaging and Tissue Correlates to Optimize Management of Glioblastoma
$2,138,843Susan M Chang · University Of California, San Francisco · P01 · FY2013 · CA
SPORE in Bladder Cancer
$2,138,532Dean F. Bajorin · Sloan-Kettering Inst Can Research · P50 · FY2021 · CA
Muscular Dystrophy Cooperative Research Center
$2,138,393University Of Washington · U54 · FY2005 · HD
Head and Neck Cancer SPORE
$2,138,140Robert L Ferris · University Of Pittsburgh At Pittsburgh · P50 · FY2022 · CA
GENERAL CLINICAL RESEARCH CENTER
$2,137,837University Of Iowa · M01 · FY2001 · RR
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
$2,137,785Roy S Herbst · Yale University · P50 · FY2024 · CA
Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping
$2,137,425Kelan G Tantisira · University Of California, San Diego · R01 · FY2025 · HL
Gene Therapy for Sickle Cell Disease
$2,137,357Arthur W. Nienhuis · St. Jude Children'S Research Hospital · P01 · FY2008 · HL
Pathobiology and treatment of patients with inborn errors of immunity
$2,137,125Sung-Yun Pai · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
SPORE in Lung Cancer
$2,136,998Paul A Bunn · University Of Colorado Denver · P50 · FY2007 · CA